AFAO Health Promotion Officer, Sean Slavin, blogs live from CROI 2015:
A cure for hepatitis C? "Mission accomplished" is the message from #CROI2015, as a range of new drugs demonstrate high efficacy with minimal side effects. A number of these have been approved for use in the US.
Implementation, however, is in its infancy and there are currently significant cost barriers with the drug manufacturers struggling to demonstrate cost effectiveness at current prices.In recent weeks competitive bidding began in the US between rival manufacturers and prices are expected to fall as more agents come onto the market.
A cure for hepatitis C? "Mission accomplished" is the message from #CROI2015, as a range of new drugs demonstrate high efficacy with minimal side effects. A number of these have been approved for use in the US.
Implementation, however, is in its infancy and there are currently significant cost barriers with the drug manufacturers struggling to demonstrate cost effectiveness at current prices.In recent weeks competitive bidding began in the US between rival manufacturers and prices are expected to fall as more agents come onto the market.
